Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Endometrial Neoplasms 2Breast Neoplasms 2Breast Carcinoma In Situ 2Paget's Disease, Mammary 1Hot Flashes 1Endometrial Adenocarcinoma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Medroxyprogesterone × Clear all
NCT00026286 2023-06-15

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast, Hot Flashes

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡